Your session is about to expire
← Back to Search
Procedure
Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes
N/A
Waitlist Available
Led By Gaby Moawad, MD
Research Sponsored by Gaby Moawad
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up perioperative
Awards & highlights
No Placebo-Only Group
Summary
This trial compares two ways of removing the uterus in pieces during minimally invasive surgery: through the vagina or a small cut in the belly. It aims to find out which method results in better surgical outcomes for women needing a hysterectomy.
Eligible Conditions
- Uterine Fibroids
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ perioperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~perioperative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Total operative time
Secondary study objectives
Blood Loss
Intraoperative complications
Post-operative complications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: abdominal morcellationActive Control1 Intervention
Women randomized to this group will undergo abdominal morcellation.
Group II: vaginal morcellationActive Control1 Intervention
Women randomized to this group will undergo vaginal morcellation.
Find a Location
Who is running the clinical trial?
Gaby MoawadLead Sponsor
2 Previous Clinical Trials
300 Total Patients Enrolled
George Washington UniversityLead Sponsor
254 Previous Clinical Trials
466,595 Total Patients Enrolled
Gaby Moawad, MDPrincipal InvestigatorGeorge Washington University Medical Faculty Associates
1 Previous Clinical Trials
120 Total Patients Enrolled